Co-reporter:Amelie Wißbrock, Toni Kühl, Katja Silbermann, Albert J. Becker, Oliver Ohlenschläger, and Diana Imhof
Journal of Medicinal Chemistry 2017 Volume 60(Issue 1) pp:
Publication Date(Web):November 29, 2016
DOI:10.1021/acs.jmedchem.6b01432
Labile heme has been suggested to have an impact in several severe diseases. In the context of Alzheimer’s disease (AD), however, decreased levels of free heme have been reported. Therefore, we were looking for an assay system that can be used for heme concentration determination. From a biochemical point of view the peroxidase activity of the Aβ-heme complex seemed quite attractive to pursue this goal. As a consequence, a peptide that is able to increase the readout even in the case of a low heme concentration is favorable. The examination of Aβ- and non-Aβ-derived peptides in complex with heme revealed that the peroxidase-like activity significantly depends on the peptide sequence and length. A 23mer His-based peptide derived from human fatty acyl-CoA reductase 1 in complex with heme exhibited a significantly higher peroxidase activity than Aβ(40)-heme. Structural modeling of both complexes demonstrated that heme binding via a histidine can be supported by hydrogen bond interactions of a basic residue near the propionate carboxyl function of protoporphyrin IX. Furthermore, the interplay of Aβ-heme and the lipoprotein LDL as a potential physiological effector of Aβ was examined.
Co-reporter:Hans Henning Brewitz;Dr. Toni Kühl;Nishit Goradia;Kerstin Galler;Dr. Jürgen Popp;Dr. Ute Neugebauer;Dr. Oliver Ohlenschläger;Dr. Diana Imhof
ChemBioChem 2015 Volume 16( Issue 15) pp:2216-2224
Publication Date(Web):
DOI:10.1002/cbic.201500331
Abstract
The importance of heme as a transient regulatory molecule has become a major focus in biochemical research. However, detailed information about the molecular basis of transient heme–protein interactions is still missing. We report an in-depth structural analysis of FeIII heme–peptide complexes by a combination of UV/Vis, resonance Raman, and 2D-NMR spectroscopic methods. The experiments reveal insights both into the coordination to the central iron ion and into the spatial arrangement of the amino acid sequences interacting with protoporphyrin IX. Cysteine-based peptides display different heme-binding behavior as a result of the existence of ordered, partially ordered, and disordered conformations in the heme-unbound state. Thus, the heme-binding mode is clearly the consequence of the nature and flexibility of the residues surrounding the iron ion coordinating cysteine. Our analysis reveals scenarios for transient binding of heme to heme-regulatory motifs in proteins and demonstrates that a thorough structural analysis is required to unravel how heme alters the structure and function of a particular protein.
Co-reporter:Ming Chen;Pascal Heimer
Amino Acids 2015 Volume 47( Issue 7) pp:1283-1299
Publication Date(Web):2015 July
DOI:10.1007/s00726-015-1982-5
This review focuses on chemical ligation methods for the preparation of oligopeptides and proteins. Chemical ligation is a practical and convenient methodology in peptide and protein synthesis. Longer peptides and proteins can be obtained with high yield in aqueous buffer solutions by coupling unprotected peptide segments even without activation by enzymes or further chemical agents. Several methods and protocols were developed in the past. The potential of the most important approaches of the thioester- and imine-ligation techniques is demonstrated by a broad spectrum of applications. In addition, special features and protocols such as the template-directed ligation, ligation with novel additives or solvent media, microwave-assisted ligation, and the achievements obtained with those are also highlighted herein.
Co-reporter:Miriam Böhm ; Charlotte A. Bäuml ; Kornelia Hardes ; Torsten Steinmetzer ; Dirk Roeser ; Yvonne Schaub ; Manuel E. Than ; Arijit Biswas
Journal of Medicinal Chemistry 2014 Volume 57(Issue 24) pp:10355-10365
Publication Date(Web):November 21, 2014
DOI:10.1021/jm501058g
The inhibition of the final step in blood coagulation, the factor XIIIa (FXIIIa) catalyzed cross-linking of fibrin monomers, is currently still a challenge in medicinal chemistry. We report synthesis, recombinant expression, disulfide connectivity, and biological activity of tridegin, the sole existing peptide representative displaying inhibitory activity on FXIIIa. Inhibition of the enzyme by this 66-mer cysteine-rich peptide is mediated by its C-terminal sequence, while the N-terminal part comprises structural information and contributes to inhibitor binding. Either of the production strategies examined leads to the formation of different disulfide-bridged isomers indicating the requirement of the correct fold for inhibitory activity. Molecular modeling and docking studies confirm disulfide bond isomer preference with respect to binding to FXIIIa, in turn, the knowledge of the enzyme–inhibitor interactions might bring about comprehensive ideas for the design of a suitable lead structure for addressing FXIIIa.
Co-reporter:Dorle Hennig;Stephanie Schubert;Harald Dargatz;Evi Kostenis;Alfred Fahr;Ulrich S. Schubert;Thorsten Heinzel
Macromolecular Bioscience 2014 Volume 14( Issue 1) pp:69-80
Publication Date(Web):
DOI:10.1002/mabi.201300213
The use of different nanoparticles (NPs) for successful encapsulation of bioactive substances is discussed. The inclusion efficiency into liposomes, acetalated dextran (Ac-Dex), and variants of poly[(lactic acid)-co-(glycolic acid)] (PLGA) NPs is analyzed after chemical degradation. Efficient inclusion of SIRT1 inhibitor Ex527 in liposomes, Ac-Dex- and PLGA-NPs is observed for all procedures used. Activity of Ex527 is demonstrated by monitoring the acetylation status of SIRT1-target p53. In contrast, small peptides are only incorporated into acid-terminated PLGA-NPs and marginally into Ac-Dex-NPs. The yield depends on peptide sequence and terminal modifications. Activity is exemplified for angiotensin II using the dynamic mass redistribution technology.
Co-reporter:Toni Kühl, Ming Chen, Kathleen Teichmann, Annegret Stark, Diana Imhof
Tetrahedron Letters 2014 Volume 55(Issue 27) pp:3658-3662
Publication Date(Web):2 July 2014
DOI:10.1016/j.tetlet.2014.04.102
•Native chemical ligation (NCL) is examined in an ionic liquid (IL) and compared to a buffer system.•Use of IL medium represents a new approach in NCL chemistry.•NCL can be performed at room-temperature without toxic additives in good yields.•Reaction time is dramatically decreased for all peptide-thioesters investigated.The ionic liquid 1-ethyl-3-methylimidazolium acetate ([C2mim][OAc]) was successfully used as alternative solvent for native chemical ligation of peptide fragments to produce model peptide LYRAXCRANK (X = G, A, L, N, Q, K, and F). The commonly used buffer system including thiol additives such as thiophenol and benzyl mercaptan can be replaced by the nontoxic ionic liquid [C2mim][OAc]. In addition to improving the solubility of the peptides in [C2mim][OAc], yields and rates of the ligation reactions were found to be efficiently enhanced.
Co-reporter:Miriam Böhm, Alesia A. Tietze, Pascal Heimer, Ming Chen, Diana Imhof
Journal of Molecular Liquids 2014 192() pp: 67-70
Publication Date(Web):
DOI:10.1016/j.molliq.2013.08.020
Co-reporter:Pascal Heimer;Dr. Alesia A. Tietze;Miriam Böhm;Dr. Ralf Giernoth;Andrea Kuchenbuch;Dr. Annegret Stark;Dr. Enrico Leipold; Dr. Stefan H. Heinemann;Dr. Christian Kt; Dr. Diana Imhof
ChemBioChem 2014 Volume 15( Issue 18) pp:2754-2765
Publication Date(Web):
DOI:10.1002/cbic.201402356
Abstract
The oxidation of the conotoxin μ-SIIIA in different ionic liquids was investigated, and the results were compared with those obtained in [C2mim][OAc]. Conversion of the reduced precursor into the oxidized product was observed in the protic ILs methyl- and ethylammonium formate (MAF and EAf, respectively), whereas choline dihydrogenphosphate and Ammoeng 110 failed to yield folded peptide. However, the quality and yield of the peptide obtained in MAF and EAF were lower than in the case of the product from [C2mim][OAc]. Reaction conditions (temperature, water content) also had an impact on peptide conversion. A closer look at the activities of μ-SIIIA versions derived from an up-scaled synthesis in [C2mim][OAc] revealed a significant loss of the effect on ion channel NaV1.4 relative to the buffer-oxidized peptide, whereas digestion of either μ-SIIIA product by trypsin was unaffected. This was attributed to adherence of ions from the IL to the peptide, because the disulfide connectivity is basically the same for the differentially oxidized μ-SIIIA versions.
Co-reporter:Toni Kühl, Amelie Wißbrock, Nishit Goradia, Nirakar Sahoo, Kerstin Galler, Ute Neugebauer, Jürgen Popp, Stefan H. Heinemann, Oliver Ohlenschläger, and Diana Imhof
ACS Chemical Biology 2013 Volume 8(Issue 8) pp:1785
Publication Date(Web):June 3, 2013
DOI:10.1021/cb400317x
Regulatory heme binds to specific motifs in proteins and controls a variety of biochemical processes. Several of these proteins were recently shown to form complexes with ferric and/or ferrous heme via a cysteine residue as axial ligand. The objective of this study was to examine the heme-binding properties of a series of cysteine-containing peptides with focus on CP motif sequences. The peptides displayed different binding behavior upon Fe(III) heme application with characteristic wavelength shifts of the Soret band to 370 nm or 420–430 nm and in some cases to both wavelengths. Whereas for most of the peptides containing a cysteine only a shift to 420–430 nm was observed, CP-containing peptides exhibited a preference for a shift to 370 nm. Detailed structural investigation using Raman and NMR spectroscopy on selected representatives revealed different binding modes with respect to iron ion coordination, which reflected the results of the UV–vis studies. A predicted short sequence stretch derived from dipeptidyl peptidase 8 was additionally examined with respect to CP motif binding to heme on the peptide as well as on the protein level. The heme association was confirmed with the first solution structure of a CP-peptide-heme complex and, moreover, an inhibitory effect of Fe(III) heme on the enzyme’s activity. The relevance of both the use of model compounds to elucidate the molecular mechanism underlying regulatory heme binding and its potential for the investigation of regulatory heme control is discussed.
Co-reporter:Alesia A. Tietze;Dr. Daniel Tietze;Dr. Oliver Ohlenschläger;Dr. Enrico Leipold;Florian Ullrich;Toni Kühl;André Mischo;Dr. Gerd Buntkowsky;Dr. Matthias Görlach;Dr. Stefan H. Heinemann;Dr. Diana Imhof
Angewandte Chemie 2012 Volume 124( Issue 17) pp:4134-4137
Publication Date(Web):
DOI:10.1002/ange.201107011
Co-reporter:Alesia A. Tietze;Dr. Daniel Tietze;Dr. Oliver Ohlenschläger;Dr. Enrico Leipold;Florian Ullrich;Toni Kühl;André Mischo;Dr. Gerd Buntkowsky;Dr. Matthias Görlach;Dr. Stefan H. Heinemann;Dr. Diana Imhof
Angewandte Chemie International Edition 2012 Volume 51( Issue 17) pp:4058-4061
Publication Date(Web):
DOI:10.1002/anie.201107011
Co-reporter:Miriam Böhm;Toni Kühl;Kornelia Hardes;Richard Coch;Dr. Christoph Arkona;Dr. Bernhard Schlott;Dr. Torsten Steinmetzer;Dr. Diana Imhof
ChemMedChem 2012 Volume 7( Issue 2) pp:326-333
Publication Date(Web):
DOI:10.1002/cmdc.201100405
Abstract
Tridegin, a 66-mer peptide isolated from the leech Haementeria ghilianii, is a potent inhibitor of the coagulation factor XIIIa. This paper describes the chemical synthesis of tridegin by two different strategies—solid-phase assembly and native chemical ligation—both followed by oxidation in solution phase. Tridegin and truncated analogues were examined for their activity and revealed a particular importance of the C-terminal region of the parent peptide. Based on these studies a minimal sequence required for factor XIIIa inhibition could be identified. Our data revealed that the glutamine residue at position 52 (Q52) of tridegin most likely binds to the active site of factor XIIIa and was therefore suggested to react with the enzyme. The function of the N-terminal region is also discussed, as the isolated C-terminal segment of tridegin lost its inhibitory activity rapidly in the presence of factor XIIIa, whereas this was not the case for the full-length inhibitor.
Co-reporter:Hans Henning Brewitz, Gregor Hagelueken, Diana Imhof
Biochimica et Biophysica Acta (BBA) - General Subjects (March 2017) Volume 1861(Issue 3) pp:683-697
Publication Date(Web):March 2017
DOI:10.1016/j.bbagen.2016.12.021
Co-reporter:Hans Henning Brewitz, Nishit Goradia, Erik Schubert, Kerstin Galler, Toni Kühl, Benjamin Syllwasschy, Jürgen Popp, Ute Neugebauer, Gregor Hagelueken, Olav Schiemann, Oliver Ohlenschläger, Diana Imhof
Biochimica et Biophysica Acta (BBA) - General Subjects (June 2016) Volume 1860(Issue 6) pp:1343-1353
Publication Date(Web):June 2016
DOI:10.1016/j.bbagen.2016.03.027